Eliem Therapeutics Inc
(NASDAQ:ELYM)
$2.51
-0.05[-1.95%]
Last update: 3:49PM (Delayed 15-Minutes)
Get Real Time Here
$2.57
0.0600[2.39%]
After-Hours
PerksBuyCompare Brokers
Open2.620Close2.510
Vol / Avg.10.612K / 13.861KMkt Cap69.207M
Day Range2.420 - 2.62052 Wk Range2.210 - 4.750

Eliem Therapeutics Stock (NASDAQ:ELYM), Quotes and News Summary

Eliem Therapeutics Stock (NASDAQ: ELYM) stock price, news, charts, stock research, profile.

Open2.620Close2.510
Vol / Avg.10.612K / 13.861KMkt Cap69.207M
Day Range2.420 - 2.62052 Wk Range2.210 - 4.750
Lisa Levin - Jul 21, 2023, 1:00PM
Lisa Levin - Jul 21, 2023, 8:13AM
Vandana Singh - Jul 20, 2023, 12:08PM
Vandana Singh - Feb 10, 2023, 9:31AM
Lisa Levin - Jan 4, 2023, 1:17PM
Vandana Singh - Oct 5, 2022, 11:20AM
Lisa Levin - Sep 23, 2022, 3:42AM
Ragothaman Srinivasan - Aug 2, 2022, 6:39PM
Vandana Singh - Aug 2, 2022, 7:58AM
Lisa Levin - Jul 25, 2022, 4:38AM
InvestorsObserver - Jul 21, 2023, 11:02AM
Seeking Alpha - Jul 21, 2023, 8:20AM
InvestorsObserver - Jul 20, 2023, 10:39AM
InvestorPlace - Jul 20, 2023, 8:59AM
TipRanks - Jul 20, 2023, 8:40AM
InvestorPlace - Jul 20, 2023, 8:35AM
InvestorPlace - Jul 20, 2023, 8:17AM
InvestorPlace - Jul 20, 2023, 8:04AM
Seeking Alpha - Jul 20, 2023, 7:36AM
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-0.150
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-03-08HC Wainwright & Co.Douglas TsaoReiteratesNeutralMaintains-6.00
2023-02-10HC Wainwright & Co.Douglas TsaoDowngradesBuyNeutral---
2022-10-28HC Wainwright & Co.Douglas TsaoInitiates Coverage OnBuyAnnounces-6.00
2022-08-16SVB LeerinkMarc GoodmanMaintainsOutperformLowers9.004.00

Related Companies

TickerCompanyChg %Mkt Cap
ELYMEliem Therapeutics0.39%70.9M
NKGNNKGen Biotech4.93%69.8M
BNRBurning Rock Biotech5%88.8M
EGRXEagle Pharmaceuticals-3.2%78.6M
SGMOSangamo Therapeutics-0.99%85.1M
Q

How do I buy Eliem Therapeutics (ELYM) stock?

A

You can purchase shares of Eliem Therapeutics (NASDAQ: ELYM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Eliem Therapeutics's (ELYM) competitors?

A

Other companies in Eliem Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Burning Rock Biotech (NASDAQ:BNR), Eagle Pharmaceuticals (NASDAQ:EGRX), Sangamo Therapeutics (NASDAQ:SGMO) and Adagene (NASDAQ:ADAG).

Q

What is the target price for Eliem Therapeutics (ELYM) stock?

A

The latest price target for Eliem Therapeutics (NASDAQ: ELYM) was reported by HC Wainwright & Co. on Wednesday, March 8, 2023. The analyst firm set a price target for 6.00 expecting ELYM to rise to within 12 months (a possible 133.46% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Eliem Therapeutics (ELYM)?

A

The stock price for Eliem Therapeutics (NASDAQ: ELYM) is $2.57 last updated November 8, 2023 at 11:16 PM UTC.

Q

Does Eliem Therapeutics (ELYM) pay a dividend?

A

There is no dividend information for Eliem Therapeutics.

Q

When is Eliem Therapeutics (NASDAQ:ELYM) reporting earnings?

A

Eliem Therapeutics’s Q4 earnings are confirmed for Monday, March 4, 2024.

Q

Is Eliem Therapeutics (ELYM) going to split?

A

There is no upcoming split for Eliem Therapeutics.

Q

What sector and industry does Eliem Therapeutics (ELYM) operate in?

A

Eliem Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.